Vertex Pharmaceuticals Inc / Ma (VRTX) shares outstanding: 253.5M
Vertex Pharmaceuticals Inc / Ma had 253.5M shares outstanding on Oct 31, 2026, down 0.1% from 253.7M a year earlier.
From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · VRTX stock page
Vertex Pharmaceuticals Inc / Ma shares outstanding by year
#522 of 3,716 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 31, 2026 | 253.5M | -0% |
| Oct 31, 2025 | 253.7M | -1% |
| Oct 31, 2024 | 257.5M | -0% |
| Oct 31, 2023 | 257.7M | +0% |
| Oct 21, 2022 | 256.7M | – |
Shares outstanding of similar companies
Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Organon | 262.6M | Oct 23, 2026 |
| Vertex Pharmaceuticals Inc / Ma | 253.5M | Oct 31, 2026 |
| Ardelyx | 251.4M | Oct 27, 2026 |
| Savara | 220.6M | Nov 9, 2026 |
| Ocular Therapeutix | 220.0M | Nov 6, 2026 |
| INSMED | 219.4M | Oct 23, 2026 |
| Structure Therapeutics | 214.8M | Oct 31, 2026 |
Questions and answers
What is Vertex Pharmaceuticals Inc / Ma's shares outstanding?
Vertex Pharmaceuticals Inc / Ma had 253.5M shares outstanding on Oct 31, 2026, down 0.1% from 253.7M a year earlier.
Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology